Sumavel Dosepro
Product Images NDC 43376-104

12 FDA label images from Zogenix, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sumavel Dosepro (NDC 43376-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zogenix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure For Sumatriptan Succinate. (Sumavel Dosepro 1)

The Chemical Structure For Sumatriptan Succinate. (Sumavel Dosepro 1)
Chemical structure diagram of the active ingredient shown on the product Sumavel DosePro by Zogenix, Inc. The structure features a bicyclic indole ring with various attached functional groups, including carboxyl and amino moieties.*
FDA Label Image

Steadily Press Sumavel Dosepro Straight Down Against Your Skin Until You Hear And Feel A Burst Of Air. There Is No Button To Push. After You Hear The Burst Of Air (whoosh), The Medicine Has Been Delivered And You Can Remove Sumavel Dosepro From Your Skin. (Sumavel Dosepro 10)

Steadily Press Sumavel Dosepro Straight Down Against Your Skin Until You Hear And Feel A Burst Of Air. There Is No Button To Push. After You Hear The Burst Of Air (whoosh), The Medicine Has Been Delivered And You Can Remove Sumavel Dosepro From Your Skin. (Sumavel Dosepro 10)
An illustration showing a hand-held device being pressed downwards with a motion arrow, accompanied by a comic-style 'whoosh' sound effect, suggesting activation or injection. The image appears to be an instructional diagram related to using the Sumavel DosePro device.*
FDA Label Image

Principal Display Panel Ndc 43376-106-01 Sumavel® Dosepro (sumatriptan Injection) Needle-free Delivery System 6 mg/0.5 mL Rx Only (Sumavel Dosepro 11)

Principal Display Panel Ndc 43376-106-01 Sumavel® Dosepro (sumatriptan Injection) Needle-free Delivery System 6 mg/0.5 mL Rx Only (Sumavel Dosepro 11)
Packaging label for Sumavel DosePro (sumatriptan injection) 6 mg/0.5 mL needle-free delivery system. The label indicates a single prefilled 0.5 mL single-dose unit for subcutaneous use only. Labeler is Zogenix, Inc. The design includes usage instructions to lift a flap to open and a barcode with the NDC 43376-106-01.*
FDA Label Image

Principal Display Panel Ndc 43376-104-01 Sumavel® Dosepro (sumatriptan Injection) Needle-free Delivery System 4 mg/0.5 mL Rx Only (Sumavel Dosepro 12)

Principal Display Panel Ndc 43376-104-01 Sumavel® Dosepro (sumatriptan Injection) Needle-free Delivery System 4 mg/0.5 mL Rx Only (Sumavel Dosepro 12)
Packaging label for Sumavel DosePro (sumatriptan injection) 4 mg/0.5 mL needle-free delivery system by Zogenix, Inc. The label shows a 1 prefilled, 0.5-mL single-dose unit for subcutaneous use only, marked Rx only. Includes manufacturer information and a barcode with NDC 43376-104-01.*
FDA Label Image

Figure 1. Time To Relief Of Cluster Headache From Time Of Injection (Sumavel Dosepro 2)

Figure 1. Time To Relief Of Cluster Headache From Time Of Injection (Sumavel Dosepro 2)
A line graph comparing the estimated percentage of patients with relief over time (0 to 25 minutes) between placebo and Sumatriptan groups. The graph shows data points for placebo (n=127) and Sumatriptan (n=131), with Sumatriptan providing higher relief percentages at all time points.*
FDA Label Image

A. Check Your Device (Sumavel Dosepro 3)

A. Check Your Device (Sumavel Dosepro 3)
An instructional diagram of the Sumavel DosePro, a needle-free injection system by Zogenix, Inc. The labeled parts include the snap-off tip, clear medication chamber, finger grips, lever, handle, and expiration date, illustrating the device's main components for user guidance.*
FDA Label Image

Stomach (abdomen) Or Thigh (Sumavel Dosepro 4)

Stomach (abdomen) Or Thigh (Sumavel Dosepro 4)
An illustration showing a human figure indicating injection sites for Sumavel DosePro on the stomach (abdomen) or thigh areas. The figure highlights where the product can be administered.*
FDA Label Image

Grip The Top And Bottom Of The Snap-off Tip. (Sumavel Dosepro 5)

Grip The Top And Bottom Of The Snap-off Tip. (Sumavel Dosepro 5)
An instructional illustration showing a hand holding the Sumavel DosePro device with indicated finger grips to demonstrate correct handling or activation technique.*
FDA Label Image

To Break Off The Snap-off Tip, Firmly Snap It Off In A Downward Motion. (Sumavel Dosepro 6)

To Break Off The Snap-off Tip, Firmly Snap It Off In A Downward Motion. (Sumavel Dosepro 6)
Illustration showing the use of the Sumavel DosePro autoinjector device. A hand is holding the device, and another hand is positioned to snap or activate it, indicated by the word 'snap' and an arrow demonstrating the motion required to use the device.*
FDA Label Image

Firmly Press The Lavender (4 mg) Or Green (6 mg) Lever All The Way Down (away From The Clear Plastic End), Until It Clicks And Locks Into The Handle. You May Feel Some Resistance – This Is Normal. Once You Have Flipped The Lever, Do Not Touch The End Of The Clear Medication Chamber. Keep The Medication Chamber Pointed Away From Your Face Or Eyes. (Sumavel Dosepro 7)

Firmly Press The Lavender (4 mg) Or Green (6 mg) Lever All The Way Down (away From The Clear Plastic End), Until It Clicks And Locks Into The Handle. You May Feel Some Resistance – This Is Normal. Once You Have Flipped The Lever, Do Not Touch The End Of The Clear Medication Chamber. Keep The Medication Chamber Pointed Away From Your Face Or Eyes. (Sumavel Dosepro 7)
Instructional illustrations for the Sumavel DosePro injection device by Zogenix, Inc. The images show how to operate the device, including a step to pull a lever and an indication of a 'click' sound signaling correct operation. Two circular icons depict actions to avoid, such as not looking directly at the needle and not holding the device incorrectly.*
FDA Label Image

Pinch And Press. (Sumavel Dosepro 8)

Pinch And Press. (Sumavel Dosepro 8)
Illustrations showing two possible injection sites for Sumavel DosePro: the stomach (abdomen) and the thigh. The images depict proper placement of the device for subcutaneous administration.*
FDA Label Image

Place Sumavel Dosepro Straight Out From The Delivery Site With The End Of The Clear Medication Chamber Against Your Skin. (Sumavel Dosepro 9)

Place Sumavel Dosepro Straight Out From The Delivery Site With The End Of The Clear Medication Chamber Against Your Skin. (Sumavel Dosepro 9)
An instructional diagram depicting proper use of the Sumavel DosePro needle-free injection system. It shows a hand positioning the device over the skin at a 90-degree angle with a line guide and a separate circle indicating not to pinch the skin before injection. The image is intended to illustrate correct injection technique for Sumavel DosePro by Zogenix, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.